2,500,000 Shares URSTADT BIDDLE PROPERTIES INC. Class A Common Stock ($0.01 Par Value) EQUITY UNDERWRITING AGREEMENT
Exhibit 1.1
2,500,000 Shares
URSTADT XXXXXX PROPERTIES INC.
Class A Common Stock
($0.01 Par Value)
September 14, 2010
Deutsche Bank Securities Inc.
00 Xxxx Xxxxxx, 0xx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
00 Xxxx Xxxxxx, 0xx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Ladies and Gentlemen:
Urstadt Xxxxxx Properties Inc., a Maryland corporation (the “Company”), proposes to sell to
Deutsche Bank Securities Inc. (the “Underwriter”) 2,500,000 shares (the “Firm Shares”) of the
Company’s Class A common stock, $0.01 par value per share (the “Common Stock”). The Company also
proposes to sell at the Underwriter’s option an aggregate of up to 250,000 additional shares of the
Company’s Common Stock (the “Option Shares,” and together with the Firm Shares, the “Shares”) as
set forth below.
In consideration of the mutual agreements contained herein and of the interests of the parties
in the transactions contemplated hereby, the parties hereto agree as follows:
1. Representations and Warranties of the Company.
The Company represents and warrants to the Underwriter as follows:
(a) The Company has filed with the Securities and Exchange Commission (the
“Commission”) a registration statement on Form S-3 (No. 333-142072) covering the
registration of the Shares and certain other securities of the Company under the Securities Act of
1933, as amended (the “1933 Act”). Promptly after execution and delivery of this
Agreement, the Company will prepare and file a prospectus supplement in accordance with the
provisions of
Rule 430B (“Rule 430B”) of the rules and regulations of the Commission under the 1933
Act (the “1933 Act Regulations”) and paragraph (b) of Rule 424 (“Rule 424(b)”) of
the 1933 Act Regulations. Any information included in such prospectus supplement that was omitted
from
1
such registration statement at the time it became effective but that is deemed to be part of
and included in such registration statement pursuant to Rule 430B is referred to as “Rule 430B
Information.” Each prospectus and prospectus supplement used in connection with the offering
of the Shares that omitted Rule 430B Information is herein called a “preliminary
prospectus.” Such registration statement, at any given time, together with the amendments
thereto at such time, the exhibits and any schedules thereto at such time, the documents
incorporated by reference therein pursuant to Item 12 of Form S-3 under the 1933 Act at such time,
the documents otherwise deemed to be a part thereof or included therein by the 1933 Act Regulations
at such time and the Rule 430B Information, are herein called, collectively, the “Registration
Statement.” Any registration statement filed pursuant to Rule 462(b) of the 1933 Act
Regulations is herein referred to as the “Rule 462(b) Registration Statement,” and after
such filing the term “Registration Statement” shall include the Rule 462(b) Registration Statement.
The final prospectus and prospectus supplement in the form first furnished (electronically or
otherwise) to the Underwriter for use in connection with the offering of the Shares (whether to
meet the requests of purchasers pursuant to Rule 173 under the 1933 Act Regulations or otherwise)
or, if not furnished to the Underwriter, in the form first filed by the Company pursuant to Rule
424(b), together with the documents incorporated by reference therein pursuant to Item 12 of Form
S-3 under the 1933 Act at the time of execution of this Agreement is herein called the
“Prospectus.” For purposes of this Agreement, all references to the Registration
Statement, any preliminary prospectus, the Prospectus or any amendment or supplement to any of the
foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic
Data Gathering, Analysis and Retrieval system (“XXXXX”).
All references in this Agreement to financial statements and schedules and other information
which is “contained,” “included” or “stated” in the Registration Statement, any preliminary
prospectus or the Prospectus (or other references of like import) shall be deemed to mean and
include all such financial statements and schedules and other information which is incorporated by
reference in or otherwise deemed by the 1933 Act Regulations to be a part of or included in the
Registration Statement, any preliminary prospectus or the Prospectus, as the case may be; and all
references in this Agreement to amendments or supplements to the Registration Statement, any
preliminary prospectus or the Prospectus shall be deemed to mean and include the filing of any
document under the Securities Exchange Act of 1934, as amended (the “1934 Act”), which is
incorporated by reference in or otherwise deemed by the 1933 Act Regulations to be a part of or
included in the Registration Statement, any preliminary prospectus or the Prospectus, as the case
may be.
(b) The Company meets the requirements for use of Form S-3 under the 1933 Act. The
Registration Statement and any post-effective amendment thereto has become effective under the 1933
Act. No stop order suspending the effectiveness of the Registration Statement has been issued
under the 1933 Act and no proceedings for that purpose have been instituted or are pending or, to
the knowledge of the Company, are contemplated by the Commission, and any request on the part of
the Commission for additional information has been complied with.
(c) At the respective times the Registration Statement and any post-effective amendment
thereto became or becomes effective, at each deemed effective date of the
2
Registration Statement
with respect to the Underwriter pursuant to Rule 430B(f)(2) of the 1933 Act Regulations and at the
Closing Date (and, if any Option Shares are purchased, at the applicable Option Closing Date), the
Registration Statement complied and will comply in all material respects with the requirements of
the 1933 Act and the 1933 Act Regulations and did not and will not contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein not misleading.
(d) The Prospectus and any amendments or supplements thereto, at the time the Prospectus or
any such amendment or supplement was issued and at the Closing Date (and, if any Option Shares are
purchased, at the applicable Option Closing Date), complied and will comply in all material
respects with the requirements of the 1933 Act and the 1933 Act Regulations and did not and will
not include an untrue statement of a material fact or omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading.
(e) Each preliminary prospectus (including any prospectus or prospectuses filed as part of the
Registration Statement at the time it originally became effective or any amendment thereto),
complied when so filed in all material respects with the requirements of the 1933 Act and the 1933
Act Regulations and each preliminary prospectus and the Prospectus delivered to the Underwriter for
use in connection with the offering of the Shares was identical to the electronically transmitted
copies thereof filed with the Commission pursuant to XXXXX, except to the extent permitted by
Regulation S-T.
(f) As of the Initial Sale Time (as defined below), neither (x) the Issuer General Use Free
Writing Prospectus(es) (as defined below) issued at or prior to the Initial Sale Time, each
preliminary prospectus issued at or prior to the Initial Sale Time and the information included on
Schedule I hereto, all considered together (collectively, the “Disclosure
Package”), nor (y) any individual Issuer Limited Use Free Writing Prospectus (as defined
below), when considered together with the Disclosure Package, included any untrue statement of a
material fact or omitted to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading.
As used in this subsection and elsewhere in this Agreement:
“Initial Sale Time” means 8:30 a.m. (Eastern time) on September 14, 2010 or such
other time as agreed by the Company and the Underwriter.
“Issuer Free Writing Prospectus” means any “issuer free writing prospectus,” as
defined in Rule 433 of the 1933 Act Regulations (“Rule 433”), relating to the Shares that
(i) is required to be filed with the Commission by the Company, (ii) is a “road show that is a
written communication” within the meaning of Rule 433(d)(8)(i), whether or not required to be filed
with the Commission, or (iii) is exempt from filing pursuant to Rule 433(d)(5)(i) because it
contains a description of the Shares or of the offering that does not reflect the final terms, in
each case in the form filed or required to be filed with the
Commission or, if not required to be filed, in the form retained in the Company’s records
pursuant to Rule 433(g).
3
“Issuer General Use Free Writing Prospectus” means any Issuer Free Writing Prospectus
that is intended for general distribution to prospective investors (other than a “road show” (as
defined in Rule 433(h)) that is not required to be filed with the Commission pursuant to Rule
433(d)(8)(i)), as evidenced by its being specified in Schedule II hereto.
“Issuer Limited Use Free Writing Prospectus” means any Issuer Free Writing Prospectus
that is not an Issuer General Use Free Writing Prospectus.
Each Issuer Free Writing Prospectus, as of its issue date and at all subsequent times through
the completion of the public offer and sale of the Shares or until any earlier date that the issuer
notified or notifies the Underwriter as described in Section 3(c) hereof, did not, does not and
will not include any information that conflicted, conflicts or will conflict with the information
contained in the Registration Statement, the Disclosure Package or the Prospectus, including any
document incorporated by reference therein and any preliminary or other prospectus deemed to be a
part thereof that has not been superseded or modified.
The representations and warranties in this subsection shall not apply to statements in or
omissions from the Registration Statement, the Disclosure Package and the Prospectus or any Issuer
Free Writing Prospectus made in reliance upon and in conformity with written information furnished
to the Company by the Underwriter expressly for use therein (the “Underwriter’s
Information”). The parties acknowledge and agree that the Underwriter’s Information consists
solely of the material included in Section 11 hereof.
(i) The documents incorporated or deemed to be incorporated by reference in the
Registration Statement, any preliminary prospectus and the Prospectus, when they became effective
or at the time they were or hereafter are filed with the Commission, complied and will comply in
all material respects with the requirements of the 1933 Act and the 1933 Act Regulations or the
1934 Act and the rules and regulations of the Commission thereunder (the “1934 Act
Regulations”), as applicable, and, when read together with the other information in the
Disclosure Package and the Prospectus, (a) at the time the Registration Statement became effective,
(b) at the earlier of the time any preliminary prospectus was first used and the Initial Sale Time
and (c) at the Closing Date (and, if any Option Shares are purchased, at each Option Closing Date),
did not and will not contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading.
(ii) At the time of filing the Registration Statement and any post-effective amendment
thereto, at the earliest time thereafter that the Company or another offering participant made a
bona fide offer (within the meaning of Rule 164(h)(2) of the 1933 Act Regulations) of the Shares
and at the date hereof, the Company was not and is not an “ineligible issuer,” as defined in Rule
405 of the 1933 Act Regulations.
(g) Each of the Company and its Subsidiaries (defined below) has been duly incorporated or
formed, as the case may be, and is validly existing as a corporation, limited liability company or
partnership, as the case may be, in good standing under the laws of the jurisdiction of its
incorporation or formation, as the case may be, and has power and authority to
own, lease and operate its properties and to conduct its business as described in the
Registration Statement, the Disclosure Package and the Prospectus and, in the case of the Company,
to enter into and perform its obligations under this Agreement. Each of the Company and the
Subsidiaries is duly qualified as a foreign entity to transact business and is in good standing in
4
each other jurisdiction in which such qualification is required, whether by reason of the ownership
or leasing of property or the conduct of business, except for such jurisdictions where the failure
to so qualify or to be in good standing would not, individually or in the aggregate, (a) result in
a material adverse change, or any development that could reasonably be expected to result in a
material adverse change, in or to the condition, financial or otherwise, or the earnings, business,
operations, management or business prospects, whether or not arising from transactions in the
ordinary course of business, of the Company and the Subsidiaries, considered as one enterprise, (b)
adversely affect the issuance, validity or enforceability of the Shares or (c) adversely affect the
consummation of the transactions contemplated by this Agreement (any of (a), (b) or (c), a
“Material Adverse Change”). All of the issued and outstanding equity interests of each Subsidiary
of the Company that is a corporation have been duly authorized and validly issued, are fully paid
and nonassessable and are owned by the Company, directly or through subsidiaries, free and clear of
any security interest, mortgage, pledge, lien, claim, restriction or encumbrance. All
corporations, partnerships, associations, limited liability companies and other entities owned or
controlled, directly or indirectly, by the Company are set forth in Schedule III hereto (the
“Subsidiaries”).
(h) The authorized, issued and outstanding capital stock of the Company as of July 31, 2010 is
as set forth in the Prospectus under the caption “Capitalization” (and any similar section or
information contained in the Disclosure Package and Prospectus (other than for subsequent
issuances, if any, pursuant to employee benefit plans described in the Registration Statement, upon
exercise of outstanding options or warrants described in the Registration Statement or under the
Company’s current dividend reinvestment plan (the “DRIP”)). The capital stock (including the
Common Stock) conforms in all material respects to the description thereof contained in the
Registration Statement, the Disclosure Package and the Prospectus. All of the issued and
outstanding shares of capital stock of the Company have been duly authorized and validly issued,
are fully paid and non-assessable and have been issued in compliance with applicable federal and
state securities laws. The Shares have been duly authorized and when issued and paid for as
contemplated herein will be validly issued, fully paid and non-assessable. None of the outstanding
shares of capital stock of the Company was issued in violation of any preemptive rights, rights of
first refusal or other similar rights to subscribe for or purchase securities of the Company.
There are no authorized or outstanding options, warrants, preemptive rights, rights of first
refusal or other rights to purchase, or equity or debt securities convertible into or exchangeable
or exercisable for, any capital stock of the Company or any of the Subsidiaries other than those
described in the Registration Statement, the Disclosure Package and the Prospectus. The
description of the Company’s stock option, stock bonus and other stock plans or arrangements, and
of the options or other rights granted thereunder, set forth in the Registration Statement, the
Disclosure Package and the Prospectus, fairly and accurately presents the material terms and
provisions of such plans, arrangements, options and rights. Neither the filing of the Registration
Statement nor the offering or sale of the Shares as contemplated by this Agreement gives rights,
other than those which have been waived or satisfied, for or relating to
the registration of any shares of Common Stock. The shares of Common Stock and common stock
of the Company are duly listed on the New York Stock Exchange.
5
(i) The Company has not, directly or indirectly, distributed and will not distribute any
offering material in connection with the offering and sale of the Shares other than any preliminary
prospectus, the Prospectus and other materials, if any, permitted under the 1933 Act and Section
3(b) hereof.
(j) The consolidated financial statements of the Company and the Subsidiaries, together with
related notes and schedules as set forth or incorporated by reference in the Registration
Statement, the Disclosure Package and the Prospectus, present fairly the financial position and the
results of operations and cash flows of the Company and the consolidated Subsidiaries, at the
indicated dates and for the indicated periods. Such financial statements and related schedules
have been prepared in accordance with generally accepted accounting principles (“GAAP”),
consistently applied throughout the periods involved, except as disclosed therein, and all
adjustments necessary for a fair presentation of results for such periods have been made. The
summary and selected consolidated financial and statistical data included or incorporated by
reference in the Registration Statement, the Disclosure Package and the Prospectus presents fairly
the information shown therein and such data has been compiled on a basis consistent with the
financial statements presented therein and the books and records of the Company. All disclosures
contained in the Registration Statement, the Disclosure Package and the Prospectus regarding
“non-GAAP financial measures” (as such term is defined by the 1933 Act Regulations) comply with
Regulation G under the 1934 Act and Item 10 of Regulation S-K under the 1933 Act, to the extent
applicable. The Company and the Subsidiaries do not have any material liabilities or obligations,
direct or contingent (including any off-balance sheet obligations or any “variable interest
entities” within the meaning of Financial Accounting Standards Board Interpretation No. 46), not
disclosed in the Registration Statement, the Disclosure Package and the Prospectus. There are no
financial statements (historical or pro forma) that are required to be included in the Registration
Statement, the Disclosure Package or the Prospectus that are not included as required.
(k)PKF LLP, who have certified certain of the financial statements filed with the Commission
as part of, or incorporated by reference in, the Registration Statement, the Disclosure Package and
the Prospectus, is an independent registered public accounting firm with respect to the Company and
the Subsidiaries within the meaning of the 1933 Act and the applicable 1933 Act Regulations and the
rules of the Public Company Accounting Oversight Board (United States) (the “PCAOB”).
(l) There are no contracts or documents which are material to the Company, which are not
described in the Registration Statement, the Disclosure Package and the Prospectus. The contracts
so described in the Registration Statement, the Disclosure Package and the Prospectus to which the
Company or any of the Subsidiaries is a party have been duly authorized, executed and delivered by
the Company or one or more of the Subsidiaries, constitute valid and binding agreements of the
Company or one or more of the Subsidiaries, and are enforceable against and by the Company or one
or more of the Subsidiaries in accordance with their respective terms,
except as may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws
affecting creditors’ rights generally or by general principles of equity. Neither the Company, the
Subsidiaries, nor, to the best of the Company’s knowledge, any other party is in material breach
of, or material default under, any such contracts.
6
(m) Except as disclosed in the Registration Statement, the Disclosure Package and the
Prospectus, neither the Company nor any of the Subsidiaries is aware of any (i) material weakness
in its internal control over financial reporting or (ii) change in internal control over financial
reporting that has materially affected, or is reasonably likely to materially affect, the Company’s
internal control over financial reporting.
(n) Solely to the extent that the Xxxxxxxx-Xxxxx Act of 2002, as amended, and the rules and
regulations promulgated by the Commission and the New York Stock Exchange thereunder (the
“Xxxxxxxx-Xxxxx Act”) has been applicable to the Company, there is and has been no failure on the
part of the Company to comply in all material respects with any provision of the Xxxxxxxx-Xxxxx
Act. The Company has taken all necessary actions to ensure that it is in compliance with all
provisions of the Xxxxxxxx-Xxxxx Act that are in effect and with which the Company is required to
comply and is actively taking steps to ensure that it will be in compliance with other provisions
of the Xxxxxxxx-Xxxxx Act not currently in effect but which will become applicable to the Company.
(o) No material labor dispute with the employees of the Company, any of the Subsidiaries or,
to the best of the Company’s knowledge, is threatened or imminent.
(p) The Company and each of the Subsidiaries owns or leases all such properties as are
necessary to its operations as now conducted or as proposed to be conducted as described in the
Registration Statement, the Disclosure Package and the Prospectus, except where the failure to so
own or lease, individually or together with all such other failures, would not result in a Material
Adverse Change. The Company and the Subsidiaries have good and marketable title in fee simple to
all of the Properties (as defined below) and other assets of the Company, free and clear of all
security interests, mortgages, pledges, liens, claims, restrictions or encumbrances of any kind,
except such as (a) are described in the Registration Statement, the Disclosure Package and the
Prospectus or (b) do not, individually or in the aggregate, materially affect the value of such
Property or assets and do not interfere with the use made and proposed to be made of such Property
or assets. All security interests, mortgages, pledges, liens, claims, restrictions and
encumbrances of any kind on or affecting the Properties or the other assets of the Company and the
Subsidiaries that are required to be disclosed in the Registration Statement, the Disclosure
Package and the Prospectus are disclosed therein. There is no violation by the Company or any
Subsidiary of any municipal, state or federal law, rule or regulation (including, but not limited
to, those pertaining to environmental matters) concerning the Properties or any part thereof which
would result in a Material Adverse Change. Each of the Properties complies in all material
respects with all applicable zoning laws, ordinances, regulations and deed restrictions or other
covenants and, if and to the extent there is a failure to comply, such failure would not,
individually or together with all such other failures, result in a Material Adverse Change or
result in a forfeiture or reversion. Neither the Company nor any of the Subsidiaries has received
any
written notice from any governmental or regulatory authority or agency of any condemnation of
or zoning change materially affecting the Properties or any part thereof, and the Company does not
know of any such condemnation or zoning change which is threatened. The leases, agreements to
purchase and mortgages to which the Company or any of the Subsidiaries is a party, and, to the
knowledge of the Company, the guaranties of third parties (a) are the legal,
7
valid and binding
obligations of the Company and the Subsidiaries, as the case may be, and, to the knowledge of the
Company, of all other parties thereto, and the Company knows of no default currently existing with
respect thereto which would result in a Material Adverse Change, and (b) conform to the
descriptions thereof set forth in the Registration Statement, the Disclosure Package and the
Prospectus. Each mortgage that the Company or any of the Subsidiaries holds on the properties
described in the Registration Statement, the Disclosure Package and the Prospectus constitutes a
valid mortgage lien for the benefit of the Company or the Subsidiary, as the case may be, on such
property.
(q) Except as set forth in the Registration Statement, the Disclosure Package and the
Prospectus, the mortgages and deeds of trust encumbering the Properties and any other assets
described in the Registration Statement, the Disclosure Package and the Prospectus are not
convertible into equity securities of the Company or any Subsidiary and none of the Company, any of
the Subsidiaries, or, to the knowledge of the Company, any other person affiliated therewith holds
a participating interest therein, and such mortgages and deeds of trust are not cross-defaulted or
cross-collateralized to any property not owned directly or indirectly by the Company or any of the
Subsidiaries.
(r) Neither the Company nor any Subsidiary is (a) in breach of, or in default under, nor has
any event occurred which with notice, lapse of time, or both would constitute a breach of or
default under (“Default”), or in the performance or observance of any obligation, agreement,
covenant or condition contained in any license, lease, indenture, mortgage, deed of trust, loan or
credit agreement or other agreement or instrument to which the Company or any Subsidiary is a party
or by which any of them or their respective properties is bound (each, an “Existing Instrument”),
except for such Defaults which would not result in a Material Adverse Change, (b) in violation of
its respective articles or certificate of incorporation, bylaws, certificate of limited partnership
or partnership agreement, certificate of formation or articles of association, or limited liability
company or operating agreement, as the case may be, or (c) in violation of any law, administrative
regulation or administrative or court decree applicable to the Company or any of the Subsidiaries
or any of their respective properties or assets, except for such violations which would not result
in a Material Adverse Change. The Company’s execution, delivery and performance of this Agreement
and consummation of the transactions contemplated hereby (a) have been duly authorized by all
necessary corporate action and will not result in any violation of the provisions of the Articles
of Incorporation, or By-Laws or other organizational documents of the Company or any of the
Subsidiaries, (b) will not conflict with or constitute a Default (as defined above) or Debt
Repayment Triggering Event (as defined below) under, or result in the creation or imposition of any
lien, charge or encumbrance upon any property or assets of the Company or any of the Subsidiaries
pursuant to, or require the consent of any other party to, any Existing Instrument, and (c) will
not result in any violation of any law, administrative regulation or administrative or court decree
applicable to the Company or any of the Subsidiaries or any of
their respective properties or assets. No consent, approval, authorization designation,
declaration or other order of, or registration or filing with, any court or other governmental or
regulatory authority or agency, is required for the Company’s execution, delivery and performance
of this Agreement and consummation of the transactions contemplated hereby, except (a) such as have
been obtained or made by the Company and are in full force and effect under the 1933 Act, (b)
8
such
as may be required under applicable state securities or blue sky laws, (c) the filing of a final
prospectus supplement relating to the Shares with the Commission, (d) such approvals as may be
required by the Financial Industry Regulatory Authority, Inc. (“FINRA”), and (e) the filing of the
listing application applicable to the Shares with the New York Stock Exchange.
As used herein, a “Debt Repayment Triggering Event” means any event or condition which gives,
or with the giving of notice or lapse of time or both would give, the holder of any note, debenture
or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to
require the repurchase, redemption or repayment of all or a portion of such indebtedness by the
Company or any of the Subsidiaries.
(s) Except as otherwise disclosed in the Registration Statement, the Disclosure Package and
the Prospectus, subsequent to the respective dates as of which information is given in the
Registration Statement, the Disclosure Package and the Prospectus: (i) there has been no Material
Adverse Change; (b) the Company and the Subsidiaries, considered as one enterprise, have not
incurred any material liability or obligation, indirect, direct or contingent, not in the ordinary
course of business, nor entered into any material transaction or agreement not in the ordinary
course of business; (c) there has been no material casualty loss or condemnation or other material
adverse event with respect to the real properties owned by the Company and the Subsidiaries
(collectively, the “Properties”); and (d) there has been no dividend or distribution of any kind
declared, paid or made by the Company or, except for dividends or distributions paid to the Company
or the Subsidiaries, any of the Subsidiaries on any class of capital stock or other equity
interests, or any repurchase or redemption by the Company or any of the Subsidiaries of any class
of capital stock or other equity interests.
(t) The Company and the Subsidiaries own or possess sufficient trademarks, trade names,
patents, patent rights, copyrights, licenses, approvals, trade secrets and other similar rights
(collectively, the “Intellectual Property Rights”) reasonably necessary to conduct their businesses
as now conducted or as proposed to be conducted as described in the Registration Statement, the
Disclosure Package and the Prospectus; and the expected expiration of any of such Intellectual
Property Rights would not result in a Material Adverse Change. Neither the Company nor any of the
Subsidiaries has knowledge that it has infringed or received any written notice of infringement or
conflict with asserted Intellectual Property Rights of others, which, individually or in the
aggregate, if the subject of any proceeding in which there were an unfavorable decision, ruling or
finding, would result in a Material Adverse Change.
(u) Commencing with its taxable year ended October 31, 1970, and through the date hereof, the
Company has been and is organized in conformity with the requirements for qualification as a real
estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended, and the
regulations and published interpretations thereunder (collectively, the
“Code”), and its method of operation has enabled enables it to meet the requirements for
qualification and taxation as a REIT under the Code. No transaction or other event has occurred or
is contemplated which would cause the Company to fail to qualify as a REIT for its current taxable
year or future taxable years.
9
(v) With respect to the officer’s certificate issued to Xxxxx & XxXxxxxx LLP in connection
with the legal opinion as to Federal income tax matters provided to the Underwriter pursuant to
Section 5(b) hereof, where representations in such officer’s certificate involve terms defined in
the Code, the Treasury regulations thereunder, published rulings of the Internal Revenue Service or
other relevant authority, the Company’s representatives, after discussions with their current and
former counsel, understand such terms and are capable of accurately making such factual
representations.
(w) To the knowledge of the Company, after inquiry of its officers and directors, there are no
affiliations or associations with FINRA among the Company’s officers, directors, or 5% or greater
stockholders, except as set forth in the Registration Statement, the Disclosure Package and the
Prospectus or as otherwise disclosed in writing to the Underwriter.
(x) Neither the Company nor, to the Company’s knowledge, any of its affiliates has taken or
will take, directly or indirectly, any action designed to or that might be reasonably expected to
cause or result in stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Shares. None of the purchases and issuances of shares of
Common Stock pursuant to the DRIP was made by the administrator of the DRIP at the request of the
Company with the purpose or intent of stabilizing or manipulating the price of any security of the
Company to facilitate the sale or resale of the Shares. The Company acknowledges that the
Underwriter may engage in transactions that stabilize, maintain or otherwise affect the price of
the Company’s Common Stock, including stabilizing bids, syndicate covering transactions and the
imposition of penalty bids and understands that any such transactions will be conducted in
accordance with applicable laws and regulations.
(y) The Company and each of the Subsidiaries is insured by recognized, financially sound and
reputable institutions with policies in such amounts and with such deductibles and covering such
risks as are generally deemed in the Company’s industry to be adequate and customary for their
businesses, including, but not limited to, policies covering real and personal property owned or
leased by the Company and the Subsidiaries against theft, damage, destruction and acts of vandalism
and, with respect to the Properties, defects in title. The Company has no reason to believe that
it or any of the Subsidiaries will not be able (i) to renew its existing insurance coverage as and
when such policies expire or (ii) to obtain comparable coverage from similar institutions as may be
necessary or appropriate to conduct its business as now conducted or as proposed to be conducted as
described in the Registration Statement, the Disclosure Package and the Prospectus, and at a cost
that would not result in a Material Adverse Change. Neither the Company nor any of the
Subsidiaries has been denied any insurance coverage which it has sought or for which it has applied
where such denial could reasonably be expected to result in a Material Adverse Change.
(z) Except as otherwise disclosed in the Registration Statement, the Disclosure Package and
the Prospectus or except as would not, individually or in the aggregate, result in a Material
Adverse Change, (a) the Company and the Subsidiaries have been and are in compliance with
applicable Environmental Laws (as defined below), (b) none of the Company, any of the Subsidiaries,
or, to the Company’s knowledge, any other owners of any of the Properties at any time or any other
party, has at any time released (as such term is defined in
10
CERCLA (as defined below)) or otherwise
disposed of Hazardous Materials (as defined below) on, to, in, under or from the Properties or any
other real properties previously owned, leased or operated by the Company or any of the
Subsidiaries, (c) neither the Company nor any of the Subsidiaries intends to use the Properties or
any subsequently acquired properties other than in compliance with applicable Environmental Laws,
(d) neither the Company nor any of the Subsidiaries has received any written notice of, or has any
knowledge of any occurrence or circumstance which, with notice or passage of time or both, would
give rise to a claim under or pursuant to any Environmental Law with respect to the Properties, any
other real properties previously owned, leased or operated by the Company or any of the
Subsidiaries, or the assets described in the Registration Statement, the Disclosure Package and the
Prospectus or arising out of the conduct of the Company or the Subsidiaries, (e) none of the
Properties are included or, to the best of the Company’s knowledge, proposed for inclusion on the
National Priorities List issued pursuant to CERCLA by the United States Environmental Protection
Agency or, to the best of the Company’s knowledge, proposed for inclusion on any similar list or
inventory issued pursuant to any other Environmental Law or issued by any other Governmental
Authority (as defined below), (f) none of the Company, any of the Subsidiaries or, to the Company’s
knowledge, any other person or entity for whose conduct any of them is or may be held responsible,
has generated, manufactured, refined, transported, treated, stored, handled, disposed, transferred,
produced or processed any Hazardous Material at any of the Properties, except in compliance with
all applicable Environmental Laws, and has not transported or arranged for the transport of any
Hazardous Material from the Properties or any other real properties previously owned, leased or
operated by the Company or any of the Subsidiaries to another property, except in compliance with
all applicable Environmental Laws, (g) no lien has been imposed on the Properties by any
Governmental Authority in connection with the presence on or off such Property of any Hazardous
Material, and (h) none of the Company, any of the Subsidiaries or any other person or entity for
whose conduct any of them is or may be held responsible, has entered into or been subject to any
consent decree, compliance order, or administrative order with respect to the Properties or any
facilities or improvements or any operations or activities thereon.
As used herein, “Hazardous Material” shall include, without limitation, any flammable
materials, explosives, radioactive materials, hazardous materials, hazardous substances, hazardous
wastes, toxic substances or related materials, asbestos, mold, petroleum, oil, petroleum products
and any hazardous material as defined by any federal, state or local environmental law, statute,
bylaw, ordinance, rule or regulation, including, without limitation, the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980, as amended, 42 U.S.C. (S)(S)
9601-9675 (“CERCLA”), the Hazardous Materials Transportation Act, as amended, 49 U.S.C. (S)(S)
1801-1819, the Resource Conservation and Recovery Act, as amended, 42 U.S.C. (S)(S) 6901-K, the
Emergency Planning and Community Right-to-Know Act of 1986, 42 U.S.C. (S)(S) 1101-11050, the Toxic
Substances Control Act, 15 U.S.C. (S)(S) 2601-2671, the Federal
Insecticide, Fungicide and Rodenticide Act, 7 U.S.C. (S)(S) 136-136y, the Clean Air Act, 42
U.S.C. (S)(S) 7401-7642, the Clean Water Act (Federal Water Pollution Control Act), 33 U.S.C.
(S)(S) 1251-1387, the Safe Drinking Water Act, 42 U.S.C. (S)(S) 300f-300j-26, and the Occupational
Safety and Health Act, 29 U.S.C. (S)(S) 651-678, and any analogous state laws, as any of the above
may be amended from time to time and in the
11
regulations promulgated pursuant to each of the
foregoing (including environmental statutes and laws not specifically defined herein)
(individually, an “Environmental Law” and collectively, the “Environmental Laws”) or by any
federal, state or local governmental authority having or claiming jurisdiction over the properties
and assets of the Company and its subsidiaries (a “Governmental Authority”).
(aa) The Company reasonably believes that with respect to the effect of Environmental Laws on
the business, operations and properties of the Company and the Subsidiaries, any capital or
operating expenditures required for clean-up or closure of properties or compliance with
Environmental Laws or any permit, license or approval, any related constraints on operating
activities and any potential liabilities to third parties would not, individually or in the
aggregate, result in a Material Adverse Change.
(bb) The Company, the Subsidiaries and any “employee benefit plan” (as defined under the
Employee Retirement Income Security Act of 1974, as amended, and the regulations and published
interpretations thereunder (collectively, “ERISA”)) established or maintained by the Company or its
ERISA Affiliates (as defined below) are in compliance in all material respects with ERISA. “ERISA
Affiliate” means, with respect to the Company, any member of any group of organizations described
in Sections 414(b), (c), (m) or (o) of the Code of which the Company is a member. No “reportable
event” (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any
“employee benefit plan” established or maintained by the Company or any of its ERISA Affiliates.
No “employee benefit plan” established or maintained by the Company or any of its ERISA Affiliates,
if such “employee benefit plan” were terminated, would have any “amount of unfunded benefit
liabilities” (as defined under ERISA). Neither the Company nor any of its ERISA Affiliates has
incurred or reasonably expects to incur any liability under (a) Title IV of ERISA with respect to
termination of, or withdrawal from, any “employee benefit plan” or (b) Sections 412, 4971, 4975 or
4980B of the Code. Each “employee benefit plan” established or maintained by the Company or any of
its ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so
qualified and nothing has occurred, whether by action or failure to act, which would cause the loss
of such qualification.
(cc) The execution and delivery of, and the performance by the Company of its obligations
under, this Agreement have been duly and validly authorized by all necessary corporate action on
the part of the Company, and this Agreement has been duly executed and delivered by the Company.
(dd) Neither the Company nor any Subsidiary is or, after giving effect to the offering and
sale of the Shares contemplated hereunder and the application of the net proceeds from such sale as
described in the Registration Statement, Disclosure Package and the Prospectus, will be an
“investment company” within the meaning of such term under the Investment Company Act
of 1940 as amended (the “1940 Act”), and the rules and regulations of the Commission
thereunder.
(ee) The Company and each of the Subsidiaries maintains a system of internal accounting
controls sufficient to provide reasonable assurances that (i) transactions are executed
12
in
accordance with management’s general or specific authorization; (ii) transactions are recorded as
necessary to permit preparation of financial statements in conformity with GAAP and to maintain
accountability for assets; (iii) access to assets is permitted only in accordance with management’s
general or specific authorization; and (iv) the recorded accountability for assets is compared with
existing assets at reasonable intervals and appropriate action is taken with respect to any
differences.
(ff) The Company has established and maintains “disclosure controls and procedures” (as
defined in Rules 13a-14(c) and 15d-14(c) under the 1934 Act); the Company’s “disclosure controls
and procedures” are reasonably designed to ensure that all information (both financial and
non-financial) required to be disclosed by the Company in the reports that it files or submits
under the 1934 Act is recorded, processed, summarized and reported within the time periods
specified in the rules and regulations of the 1934 Act, and that all such information is
accumulated and communicated to the Company’s management as appropriate to allow timely decisions
regarding required disclosure and to make the certifications of the Chief Executive Officer and
Chief Financial Officer of the Company required under the 1934 Act with respect to such reports.
(gg) The statistical, industry-related and market-related data included in the Registration
Statement, the Disclosure Package and the Prospectus are based on or derived from sources which the
Company reasonably and in good faith believes are reliable and accurate, and such data agree with
the sources from which they are derived.
(hh) The operations of the Company and the Subsidiaries are and have been conducted at all
times in compliance with applicable financial record-keeping and reporting requirements of the
Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering
statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering
Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority
or body or any arbitrator involving the Company or any of the Subsidiaries with respect to the
Money Laundering Laws is pending or, to the Company’s knowledge, threatened.
(ii) Neither the Company nor, to the Company’s knowledge, any director, officer, agent,
employee or affiliate of the Company is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not
directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make
available such proceeds to any subsidiary, joint venture partner or other person or entity, for the
purpose of financing the activities of any person currently subject to any U.S. sanctions
administered by OFAC.
(jj) The Shares have been approved for listing subject to notice of issuance on the New York
Stock Exchange.
(kk) There are no relationships or related-party transactions involving the Company or any of
the Subsidiaries or any other person required to be described in the Registration
13
Statement, the
Disclosure Package and the Prospectus which have not been described as required.
(ll) Neither the Company nor any of the Subsidiaries has made any contribution or other
payment to any official of, or candidate for, any federal, state or foreign office in violation of
any law which violation is required to be disclosed in the Registration Statement, the Disclosure
Package and the Prospectus.
(mm) As of the date of the initial filing of the Registration Statement, there were no
outstanding personal loans made, directly or indirectly, by the Company to any director or
executive officer of the Company.
(nn) None of the information on (or hyperlinked from) the Company’s website at
xxx.xxxxxxxxxxxx.xxx includes or constitutes a “free writing prospectus” as defined in Rule 405
under the 1933 Act and the Company does not maintain or support any website other than
xxx.xxxxxxxxxxxx.xxx.
(oo) No Subsidiary is currently prohibited, directly or indirectly, from paying any dividends
to the Company, from making any other distribution on such Subsidiary’s capital stock, from
repaying to the Company any loans or advances to such Subsidiary from the Company or from
transferring any of such Subsidiary’s property or assets to the Company or any other Subsidiary of
the Company where such prohibition has had or could reasonably be expected to result in a Material
Adverse Change.
(pp) Neither the Company nor any of the Subsidiaries nor any director, officer, agent,
employee or affiliate of the Company or any of the Subsidiaries is aware of or has taken any
action, directly or indirectly, that would result in a violation by such Persons of the Foreign
Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”),
including, without limitation, making use of the mails or any means or instrumentality of
interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization
of the payment of any money, or other property, gift, promise to give, or authorization of the
giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any
foreign political party or official thereof or any candidate for foreign political office, in
contravention of the FCPA and the Company, its subsidiaries and its affiliates have conducted their
businesses in compliance with the FCPA and have instituted and maintain policies and procedures
designed to ensure, and which are reasonably expected to continue to ensure, continued compliance
therewith.
2. Purchase, Sale and Delivery of the Firm Shares.
(a) On the basis of the representations, warranties and covenants herein contained, and
subject to the conditions herein set forth, the Company agrees to sell to the Underwriter and the
Underwriter agrees to purchase, at a price of $18.05 per share, the Firm Shares.
(b) Payment for the Firm Shares to be sold hereunder is to be made in Federal (same day) funds
to an account or accounts designated in writing by the Company against delivery of
14
the Firm Shares
to the Underwriter through the facilities of The Depository Trust Company, New York, New York at
10:00 a.m., New York time, pursuant to the written instructions of the Underwriter, on the third
business day after the date of this Agreement or at such other time and date not later than five
business days thereafter as the Underwriter and the Company shall agree upon, such time and date
being herein referred to as the “Closing Date.” (As used herein, “business day” means a day on
which the New York Stock Exchange is open for trading and on which banks in New York are open for
business and are not permitted by law or executive order to be closed).
(c) In addition, on the basis of the representations and warranties herein contained and
subject to the terms and conditions herein set forth, the Company hereby grants an option to the
Underwriter to purchase the Option Shares at the price per share as set forth in the first
paragraph of this Section 2. The option granted hereby may be exercised in whole or in part, in no
more than two installments, by giving written notice (i) at any time before the Closing Date and
(ii) thereafter within 30 days after the date of this Agreement by the Underwriter, to the Company
setting forth the number of Option Shares as to which the Underwriter is exercising the option and
the time and date at which Option Shares are to be delivered. The time and date at which Option
Shares are to be delivered shall be determined by the Underwriter but shall not be earlier than
three nor later than 10 full business days after the exercise of such option, nor in any event
prior to the Closing Date (each such time and date being herein referred to as the “Option Closing
Date”). If the date of exercise of the option is three or more days before the Closing Date, the
notice of exercise shall set the Closing Date as the Option Closing Date. The option with respect
to the Option Shares granted hereunder may be exercised only to cover over-allotments in the sale
of the Firm Shares by the Underwriter. The Underwriter may cancel such option at any time prior to
its expiration by giving written notice of such cancellation to the Company. To the extent, if
any, that the option is exercised, payment for the Option Shares shall be made on the Option
Closing Date in Federal (same day) funds to an account or accounts designated in writing by the
Company against delivery of the Option Shares to the Underwriter through the facilities of The
Depository Trust Company in New York, New York pursuant to the written instructions of the
Underwriter.
15
3. Covenants of the Company.
The Company covenants and agrees with the Underwriter that:
(a) The Company will (A) prepare and timely file with the Commission under Rule 424(b) a
Prospectus in a form approved by the Underwriter containing information previously omitted at the
time of effectiveness of the Registration Statement in reliance on Rules 430A, 430B or 430C under
the 1933 Act, and (B) not file any amendment to the Registration Statement with respect to the
Common Stock or distribute an amendment or supplement to the Disclosure Package or the Prospectus
or document incorporated by reference therein of which the Underwriter shall not previously have
been advised and furnished with a copy or to which the Underwriter shall have reasonably objected
in writing or which is not in compliance with the 1933 Act and the 1933 Act Regulations and (C)
file on a timely basis all reports and any definitive proxy or information statements required to
be filed by the Company with the Commission subsequent to the date of the Prospectus and prior to
the termination of the offering of the Shares by the Underwriter.
(b) The Company will (i) not make any offer relating to the Shares that would constitute an
Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as
defined in Rule 405 under the 0000 Xxx) required to be filed by the Company with the Commission
under Rule 433 unless the Underwriter approves its use in writing prior to first use (each, a
“Permitted Free Writing Prospectus”); provided that the prior written consent of the Underwriter
hereto shall be deemed to have been given in respect of the Issuer General Use Free Writing
Prospectus(es) included in Schedule II hereto, (ii) treat each Permitted Free Writing
Prospectus as an Issuer Free Writing Prospectus, (iii) comply with the requirements of Rules 164
and 433 under the 1933 Act applicable to any Issuer Free Writing Prospectus, including the
requirements relating to timely filing with the Commission, legending and record keeping and (iv)
not take any action that would result in the Underwriter or the Company being required to file with
the Commission pursuant to Rule 433(d) a free writing prospectus prepared by or on behalf of the
Underwriter that the Underwriter otherwise would not have been required to file thereunder. The
Company will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission
any electronic road show.
(c) The Company will advise the Underwriter promptly (A) of receipt of any comments from the
Commission, (C) of any request of the Commission for amendment of the Registration Statement or for
supplement to the Disclosure Package or the Prospectus or for any additional information, and (D)
of the issuance by the Commission of any stop order suspending the effectiveness of the
Registration Statement or any order preventing or suspending the use of any preliminary prospectus,
any Issuer Free Writing Prospectus or the Prospectus, or of the institution of any proceedings for
that purpose or pursuant to Section 8A of the 1933 Act. The Company will use its best efforts to
prevent the issuance of any such order and to obtain as soon as possible the lifting thereof, if
issued.
(d) The Company will cooperate with the Underwriter in endeavoring to qualify the Shares for
sale under the securities laws of such jurisdictions as the Underwriter may reasonably
have designated in writing and will make such applications, file such documents, and furnish
16
such information as may be reasonably required for that purpose, provided the Company shall not be
required to qualify as a foreign corporation or to file a general consent to service of process in
any jurisdiction where it is not now so qualified or required to file such a consent. The Company
will, from time to time, prepare and file such statements, reports, and other documents, as are or
may be required to continue such qualifications in effect for so long a period as the Underwriter
may reasonably request for distribution of the Shares.
(e) The Company will deliver to, or upon the order of, the Underwriter, from time to time, as
many copies of any preliminary prospectus as the Underwriter may reasonably request. The Company
will deliver to, or upon the order of, the Underwriter, from time to time, as many copies of any
Issuer Free Writing Prospectus as the Underwriter may reasonably request. The Company will deliver
to, or upon the order of, the Underwriter during the period when delivery of a Prospectus (or, in
lieu thereof, the notice referred to under Rule 173(a) under the 1933 Act) (the “Prospectus
Delivery Period”) is required under the 1933 Act, as many copies of the Prospectus in final form,
or as thereafter amended or supplemented, as the Underwriter may reasonably request. The Company
will deliver to the Underwriter at or before the Closing Date, four conformed copies of the
Registration Statement and all amendments thereto including all exhibits filed therewith, and will
deliver to the Underwriter such number of copies of the Registration Statement (including such
number of copies of the exhibits filed therewith that may reasonably be requested), including
documents incorporated by reference therein, and of all amendments thereto, as the Underwriter may
reasonably request. The foregoing delivery requirements may be satisfied by the delivery of an
electronic pdf. copy.
(f) The Company will comply with the 1933 Act and the 1933 Act Regulations, and the 1934 Act,
and the rules and regulations of the Commission thereunder, so as to permit the completion of the
distribution of the Shares as contemplated in this Agreement and the Prospectus. If during the
period in which a prospectus (or, in lieu thereof, the notice referred to under Rule 173(a) under
the 0000 Xxx) is required by law to be delivered by the Underwriter or dealer, any event shall
occur as a result of which, in the judgment of the Company or in the reasonable opinion of the
Underwriter, it becomes necessary to amend or supplement the Prospectus in order to make the
statements therein, in the light of the circumstances existing at the time the Prospectus is
delivered to a purchaser, not misleading, or, if it is necessary at any time to amend or supplement
the Prospectus to comply with any law, the Company promptly will either (i) prepare and file with
the Commission an appropriate amendment to the Registration Statement or supplement to the
Prospectus or (ii) prepare and file with the Commission an appropriate filing under the 1934 Act
which shall be incorporated by reference in the Prospectus so that the Prospectus as so amended or
supplemented will not, in the light of the circumstances when it is so delivered, be misleading, or
so that the Prospectus will comply with the law.
(g) If the Disclosure Package is being used to solicit offers to buy the Shares at a time when
the Prospectus is not yet available to prospective purchasers and any event shall occur as a result
of which, in the judgment of the Company or in the reasonable opinion of the Underwriter, it
becomes necessary to amend or supplement the Disclosure Package in order to make the statements
therein, in the light of the circumstances, not misleading, or to make the statements
therein not conflict with the information contained in the Registration Statement then on
file, or if it is necessary at any time to amend or supplement the Disclosure Package to comply
with any
17
law, the Company promptly will either (i) prepare, file with the Commission (if required)
and furnish to the Underwriter and any dealers an appropriate amendment or supplement to the
Disclosure Package or (ii) prepare and file with the Commission an appropriate filing under the
1934 Act which shall be incorporated by reference in the Disclosure Package so that the Disclosure
Package as so amended or supplemented will not, in the light of the circumstances, be misleading or
conflict with the Registration Statement then on file, or so that the Disclosure Package will
comply with law.
(h) The Company will make generally available to its security holders, as soon as it is
practicable to do so, but in any event not later than 15 months after the effective date of the
Registration Statement, an earnings statement (which need not be audited) in reasonable detail,
covering a period of at least 12 consecutive months beginning after the effective date of the
Registration Statement, which earnings statement shall satisfy the requirements of Section 11(a) of
the 1933 Act and Rule 158 under the 1933 Act and will advise you in writing when such statement has
been so made available.
(i) Prior to the Closing Date, the Company will furnish to the Underwriter, as soon as they
have been prepared by or are available to the Company, a copy of any unaudited interim financial
statements of the Company for any period subsequent to the period covered by the most recent
financial statements appearing in the Registration Statement, the Disclosure Package and the
Prospectus.
(j) Other than pursuant to the DRIP and other compensation and stock plans identified in the
Registration Statement, Disclosure Package and the Prospectus, no offering, sale, short sale or
other disposition of any shares of Common Stock of the Company or other securities convertible into
or exchangeable or exercisable for shares of Common Stock or derivative of Common Stock (or
agreement for such) will be made for a period of 90 days after the date of the Prospectus, directly
or indirectly, by the Company otherwise than hereunder or with the prior written consent of the
Underwriter. Notwithstanding the foregoing, if (1) during the last 17 days of the 90-day
restricted period, the Company issues an earnings release or material news or a material event
relating to the Company occurs; or (2) prior to the expiration of the 90-day restricted period, the
Company announces that it will release earnings results during the 16-day period following the last
day of the 90-day restricted period, then in each case the restrictions imposed by this paragraph
shall continue to apply until the expiration of the 18-day period beginning on the date of the
release of the earnings results or the occurrence of material news or a material event relating to
the Company, as the case may be, unless the Underwriter waives, in writing, such extension.
(k) The Company will use its best efforts to maintain the listing of the Shares on the NYSE.
(l) The Company has caused each officer and director of the Company to furnish to you, on or
prior to the date of this agreement, a letter or letters, substantially in the form attached hereto
as Exhibit A (the “Lockup Agreement”).
18
(m) The Company shall apply the net proceeds of its sale of the Shares as set forth in the
Registration Statement, Disclosure Package and the Prospectus and shall file such reports with the
Commission with respect to the sale of the Shares and the application of the proceeds therefrom as
may be required in accordance with Rule 463 under the 1933 Act.
(n) The Company shall not invest, or otherwise use the proceeds received by the Company from
its sale of the Shares in such a manner as would require the Company or any of the Subsidiaries to
register as an investment company under the 0000 Xxx.
(o) The Company will maintain a transfer agent and, if necessary under the jurisdiction of
incorporation of the Company, a registrar for the Common Stock.
The Company will not take, directly or indirectly, any action designed to cause or result in,
or that has constituted or might reasonably be expected to constitute, the stabilization or
manipulation of the price of any securities of the Company.
4. Costs and Expenses.
The Company will pay all costs, expenses and fees incident to the performance of the
obligations of the Company under this Agreement, including, without limiting the generality of the
foregoing, the following: accounting fees of the Company; the fees and disbursements of counsel
for the Company; any roadshow expenses; the cost of printing and delivering to, or as requested by,
the Underwriter copies of the Registration Statement, preliminary prospectuses, the Issuer Free
Writing Prospectuses, the Prospectus, this Agreement, any Blue Sky Survey and any supplements or
amendments thereto; the filing fees of the Commission; the filing fees and expenses (including
legal fees and disbursements) incident to securing any required review by FINRA of the terms of the
sale of the Shares; the Listing Fee of the New York Stock Exchange; the costs and expenses
(including without limitation any damages or other amounts payable in connection with legal or
contractual liability) associated with the reforming of any contracts for sale of the Shares made
by the Underwriter caused by a breach of the representation in Section 1; and the expenses,
including the fees and disbursements of counsel for the Underwriter, incurred in connection with
the qualification of the Shares under State securities or Blue Sky laws. The Company shall not,
however, be required to pay for any of the Underwriter’s expenses (other than those related to
qualification under FINRA regulation and State securities or Blue Sky laws) except that, if this
Agreement shall not be consummated because the conditions in Section 5 hereof are not satisfied, or
because this Agreement is terminated by the Underwriter pursuant to Section 9 hereof, or by reason
of any failure, refusal or inability on the part of the Company to perform any undertaking or
satisfy any condition of this Agreement or to comply with any of the terms hereof on its part to be
performed, unless such failure, refusal or inability is due primarily to the default or omission of
the Underwriter, the Company shall reimburse the Underwriter for reasonable out-of-pocket expenses,
including fees and disbursements of counsel, reasonably incurred in connection with the offering of
the Shares or in contemplation of performing its obligations hereunder; but the Company shall not
in any event be liable to the Underwriter for damages on account of loss of anticipated profits
from the sale by it of the Shares.
5. Conditions of Obligations of the Underwriter.
19
The obligations of the Underwriter to purchase the Firm Shares on the Closing Date and the
Option Shares, if any, on the Option Closing Date are subject to the accuracy, as of the Initial
Sale Time, the Closing Date or the Option Closing Date, as the case may be, of the representations
and warranties of the Company contained herein, and to the performance by the Company of its
covenants and obligations hereunder and to the following additional conditions:
(a) The Registration Statement and all post-effective amendments thereto shall have become
effective and the Prospectus and each Issuer Free Writing Prospectus required shall have been filed
as required by Rules 424, 430A, 430B, 430C or 433 under the 1933 Act, as applicable, within the
time period prescribed by, and in compliance with, the 1933 Act Regulations, and any request of the
Commission for additional information (to be included in the Registration Statement or otherwise)
shall have been disclosed to the Underwriter and complied with to its reasonable satisfaction. No
stop order suspending the effectiveness of the Registration Statement, as amended from time to
time, shall have been issued and no proceedings for that purpose or pursuant to Section 8A under
the 1933 Act shall have been taken or, to the knowledge of the Company, shall be contemplated or
threatened by the Commission and no injunction, restraining order or order of any nature by a
Federal or state court of competent jurisdiction shall have been issued as of the Closing Date
which would prevent the issuance of the Shares.
(b) The Underwriter shall have received on the Closing Date or the Option Closing Date, as the
case may be, the opinions of Xxxxx & XxXxxxxx LLP, counsel for the Company, substantially in the
forms of Exhibits B and B-1 hereto, dated the Closing Date or the Option Closing
Date, as the case may be, addressed to the Underwriter (and stating that it may be relied upon by
counsel to the Underwriter) and their negative assurance letter substantially in the form of
Exhibit B-2 hereto, dated the Closing Date or the Option Closing Date, as the case may be,
addressed to the Underwriter. The Underwriter shall have received on the Closing Date or the
Option Closing Date, as the case may be, the opinion of Miles & Stockbridge, P.C., Maryland counsel
for the Company, substantially in the form of Exhibit C hereto, dated the Closing Date or
the Option Closing Date, as the case may be, addressed to the Underwriter (and stating that it may
be relied upon by counsel to the Underwriter). The Underwriter shall have received on the Closing
Date or the Option Closing Date, as the case may be, the opinion of Xxxxxx X. Xxxxx, Executive Vice
President, Secretary and Chief Legal Officer of the Company, substantially in the form of
Exhibit D hereto, dated the Closing Date or the Option Closing Date, as the case may be,
addressed to the Underwriter (and stating that it may be relied upon by counsel to the
Underwriter).
(c) The Underwriter shall have received from Hunton & Xxxxxxxx LLP, counsel for the
Underwriter, an opinion dated the Closing Date or the Option Closing Date, as the case may be.
(d) The Underwriter shall have received at or prior to the Closing Date from Hunton & Xxxxxxxx
LLP a memorandum or summary, in form and substance satisfactory to the Underwriter, with respect to
the qualification for offering and sale by the Underwriter of the Shares under the State securities
or Blue Sky laws of such jurisdictions as the Underwriter may reasonably have designated to the
Company (the “Blue Sky Survey”).
20
(e) At the Closing Date or the Option Closing Date, as the case may be, there shall not have
been, since the date hereof or since the respective dates as of which information is given in the
Disclosure Package and the Prospectus (exclusive of any amendments or supplements thereto
subsequent to the date of this Agreement), any Material Adverse Change.
(f) The Underwriter shall have received, on each of the date hereof, the Closing Date and, if
applicable, the Option Closing Date, a letter dated the date hereof, the Closing Date or the Option
Closing Date, as the case may be, in form and substance satisfactory to the Underwriter, of PKF LLP
confirming that they are an independent registered public accounting firm with respect to the
Company and the Subsidiaries within the meaning of the 1933 Act and the applicable 1933 Act
Regulations and the rules of the PCAOB and stating that in their opinion the financial statements
and schedules examined by them and included or incorporated by reference in the Registration
Statement, the Disclosure Package and the Prospectus comply in form in all material respects with
the applicable accounting requirements of the 1933 Act and the related 1933 Act Regulations; and
containing such other statements and information as is ordinarily included in accountants’ “comfort
letters” to Underwriters with respect to the financial statements and certain financial and
statistical information contained in the Registration Statement, the Disclosure Package and the
Prospectus.
(g) The Underwriter shall have received on the Closing Date and, if applicable, the Option
Closing Date, as the case may be, a certificate or certificates of the Chief Executive Officer and
the Chief Financial Officer of the Company to the effect that, as of the Closing Date or the Option
Closing Date, as the case may be, each of them severally represents as follows:
(i) The Registration Statement has become effective under the 1933 Act and no stop order
suspending the effectiveness of the Registration Statement or no order preventing or suspending the
use of any preliminary prospectus, any Issuer Free Writing Prospectus or the Prospectus has been
issued, and no proceedings for such purpose or pursuant to Section 8A of the 1933 Act have been
taken or are, to his or her knowledge, contemplated or threatened by the Commission;
(ii) The representations and warranties of the Company contained in Section 1 hereof are true
and correct as of the Closing Date or the Option Closing Date, as the case may be;
(iii) All filings required to have been made pursuant to Rules 424, 430A, 430B or 430C under
the 1933 Act have been made as and when required by such rules;
(iv) He or she has carefully examined the Disclosure Package and any individual Issuer Limited
Use Free Writing Prospectus and, in his or her opinion, as of the Applicable Time, the statements
contained in the Disclosure Package and any individual Issuer
Limited Use Free Writing Prospectus did not contain any untrue statement of a material fact,
and such Disclosure Package and any individual Issuer Limited Use Free Writing Prospectus, when
considered together with the Disclosure Package, did not omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading;
21
(v) He or she has carefully examined the Registration Statement and, in his or her opinion, as
of the effective date of the Registration Statement, the Registration Statement did not contain any
untrue statement of a material fact and did not omit to state a material fact necessary in order to
make the statements therein not misleading, and since the effective date of the Registration
Statement, no event has occurred which should have been set forth in a supplement to or an
amendment of the Prospectus which has not been so set forth in such supplement or amendment;
(vi) He or she has carefully examined the Prospectus and, in his or her opinion, as of its
date and the Closing Date or the Option Closing Date, as the case may be, the Prospectus and any
amendments and supplements thereto did not contain any untrue statement of a material fact and did
not omit to state a material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading; and
(vii) Since the respective dates as of which information is given in the Registration
Statement, the Disclosure Package and Prospectus, there has not been any Material Adverse Change
(as defined in this Agreement) or any development which could reasonably be expected to have a
material adverse change in or on the business, management, properties, assets, rights, operations,
condition (financial or otherwise) or prospects of the Company and the Subsidiaries taken as a
whole, whether or not arising in the ordinary course of business.
(h) The Firm Shares and Option Shares, if any, have been approved for listing, subject to
notice of issuance, on the New York Stock Exchange.
(i) The Lockup Agreements described in Section 3(1) are in full force and effect.
(j) The opinions and certificates mentioned in this Agreement shall be deemed to be in
compliance with the provisions hereof only if they are in all material respects satisfactory to the
Underwriter and to Hunton & Xxxxxxxx LLP, counsel for the Underwriter.
If any of the conditions hereinabove provided for in this Section 5 shall not have been
fulfilled when and as required by this Agreement to be fulfilled, the obligations of the
Underwriter hereunder may be terminated by the Underwriter by notifying the Company of such
termination in writing or by telegram at or prior to the Closing Date or the Option Closing Date,
as the case may be.
In such event, the Company and the Underwriter shall not be under any obligation to each other
(except to the extent provided in Sections 4 and 7 hereof).
6. Conditions of the Obligations of the Company.
The obligations of the Company to sell and deliver the portion of the Shares required to be
delivered as and when specified in this Agreement are subject to the conditions that at the Closing
Date or the Option Closing Date, as the case may be, no stop order suspending the effectiveness of
22
the Registration Statement shall have been issued and in effect or proceedings therefor initiated
or threatened.
7. Indemnification.
(a) The Company agrees:
(i) to indemnify and hold harmless the Underwriter, the directors and officers of the
Underwriter and each person, if any, who controls the Underwriter within the meaning of either
Section 15 of the 1933 Act or Section 20 of the 1934 Act, against any losses, claims, damages or
liabilities to which the Underwriter or any such controlling person may become subject under the
1933 Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions or
proceedings in respect thereof) arise out of or are based upon (i) any untrue statement or alleged
untrue statement of any material fact contained in the Registration Statement, any preliminary
prospectus, any Issuer Free Writing Prospectus, the Disclosure Package and the Prospectus or any
amendment or supplement thereto, (ii) with respect to the Registration Statement, the omission or
alleged omission to state therein a material fact required to be stated therein or necessary to
make the statements therein not misleading or (iii) with respect to any preliminary prospectus,
any Issuer Free Writing Prospectus, the Disclosure Package, the Prospectus or any amendment or
supplement thereto, the omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading in the light of the
circumstances under which they were made; provided, however, that the Company will not be liable in
any such case to the extent that any such loss, claim, damage or liability arises out of or is
based upon an untrue statement or alleged untrue statement, or omission or alleged omission made in
the Registration Statement, any preliminary prospectus, any Issuer Free Writing Prospectus, the
Disclosure Package and the Prospectus, or such amendment or supplement, in reliance upon and in
conformity with written information furnished to the Company by or through the Underwriter
specifically for use therein, it being understood and agreed that the only such information
furnished by the Underwriter consists of the information described as such in Section 11 herein;
and
(ii) to reimburse the Underwriter, the Underwriter’s directors and officers, and each such
controlling person upon demand for any legal or other out-of-pocket expenses reasonably incurred by
the Underwriter or such controlling person in connection with investigating or defending any such
loss, claim, damage or liability, action or proceeding or in responding to a subpoena or
governmental inquiry related to the offering of the Shares, whether or not the Underwriter or
controlling person is a party to any action or proceeding. In the event that it is finally
judicially determined that the Underwriter was not entitled to receive payments for legal and other
expenses pursuant to this subparagraph, the Underwriter will promptly return all sums that had been
advanced pursuant hereto.
(b) The Underwriter will indemnify and hold harmless the Company, each of its directors, each
of its officers who have signed the Registration Statement, and each person, if any, who controls
the Company within the meaning of the 1933 Act, against any losses,
claims, damages or liabilities
to which the Company or any such director, officer, or controlling person may become subject under
the 1933 Act or otherwise, insofar as such losses, claims, damages or
23
liabilities (or actions or
proceedings in respect thereof) arise out of or are based upon (i) any untrue statement or alleged
untrue statement of any material fact contained in the Registration Statement, any preliminary
prospectus, any Issuer Free Writing Prospectus, the Disclosure Package, the Prospectus or any
amendment or supplement thereto, (ii) with respect to the Registration Statement or any amendment
or supplement thereto, the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not misleading or (iii) with
respect to any preliminary prospectus, any Issuer Free Writing Prospectus, the Disclosure Package,
the Prospectus or any amendment or supplement thereto, the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein
not misleading in the light of the circumstances under which they were made; and will reimburse any
legal or other expenses reasonably incurred by the Company or any such director, officer, or
controlling person in connection with investigating or defending any such loss, claim, damage,
liability, action or proceeding; provided, however, that the Underwriter will be liable in each
case to the extent, but only to the extent, that such untrue statement or alleged untrue statement
or omission or alleged omission has been made in the Registration Statement, any preliminary
prospectus, any Issuer Free Writing Prospectus, the Disclosure Package, the Prospectus or such
amendment or supplement, in reliance upon and in conformity with written information furnished to
the Company by or through the Underwriter specifically for use therein, it being understood and
agreed that the only such information furnished by any Underwriter consists of the information
described as such in Section 11 herein. This indemnity agreement will be in addition to any
liability which the Underwriter may otherwise have.
(c) In case any proceeding (including any governmental investigation) shall be instituted
involving any person in respect of which indemnity may be sought pursuant to this Section 7, such
person (the “indemnified party”) shall promptly notify the person against whom such indemnity may
be sought (the “indemnifying party”) in writing. No indemnification provided for in Section 7(a)
or (b) shall be available to any party who shall fail to give notice as provided in this Section
7(c) if the party to whom notice was not given was unaware of the proceeding to which such notice
would have related and was materially prejudiced by the failure to give such notice, but the
failure to give such notice shall not relieve the indemnifying party or parties from any liability
which it or they may have to the indemnified party for contribution or otherwise than on account of
the provisions of Section 7(a) or (b). In case any such proceeding shall be brought against any
indemnified party and it shall notify the indemnifying party of the commencement thereof, the
indemnifying party shall be entitled to participate therein and, to the extent that it shall wish,
jointly with any other indemnifying party similarly notified, to assume the defense thereof, with
counsel satisfactory to such indemnified party and shall pay as incurred the fees and disbursements
of such counsel related to such proceeding. In any such proceeding, any indemnified party shall
have the right to retain its own counsel at its own expense. Notwithstanding the foregoing, the
indemnifying party shall pay as incurred (or within 30 days of
presentation) the fees and expenses of the counsel retained by the
indemnified party in the
event (i) the indemnifying party and the indemnified party shall have mutually agreed to the
retention of such counsel, (ii) the named parties to any such proceeding (including any impleaded
parties) include both the indemnifying party and the indemnified party and representation of both
parties by the same counsel would be inappropriate due to actual or
24
potential differing interests
between them or (iii) the indemnifying party shall have failed to assume the defense and employ
counsel acceptable to the indemnified party within a reasonable period of time after notice of
commencement of the action. Such firm shall be designated in writing by you in the case of parties
indemnified pursuant to Section 7(a) and by the Company in the case of parties indemnified pursuant
to Section 7(b). The indemnifying party shall not be liable for any settlement of any proceeding
effected without its written consent but if settled with such consent or if there be a final
judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party in
accordance with the terms of this Section 7 from and against any loss or liability by reason of
such settlement or judgment. In addition, the indemnifying party will not, without the prior
written consent of the indemnified party, settle or compromise or consent to the entry of any
judgment in any pending or threatened claim, action or proceeding of which indemnification may be
sought hereunder (whether or not any indemnified party is an actual or potential party to such
claim, action or proceeding) unless such settlement, compromise or consent includes an
unconditional release of each indemnified party from all liability arising out of such claim,
action or proceeding.
(d) To the extent the indemnification provided for in this Section 7 is unavailable to or
insufficient to hold harmless an indemnified party under Section 7(a) or (b) above in respect of
any losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred
to therein, then each indemnifying party shall contribute to the amount paid or payable by such
indemnified party as a result of such losses, claims, damages or liabilities (or actions or
proceedings in respect thereof) in such proportion as is appropriate to reflect the relative
benefits received by the Company on the one hand and the Underwriter on the other from the offering
of the Shares. If, however, the allocation provided by the immediately preceding sentence is not
permitted by applicable law then each indemnifying party shall contribute to such amount paid or
payable by such indemnified party in such proportion as is appropriate to reflect not only such
relative benefits but also the relative fault of the Company on the one hand and the Underwriter on
the other in connection with the statements or omissions which resulted in such losses, claims,
damages or liabilities (or actions or proceedings in respect thereof), as well as any other
relevant equitable considerations. The relative benefits received by the Company on the one hand
and the Underwriter on the other shall be deemed to be in the same proportion as the total net
proceeds from the offering (before deducting expenses) received by the Company bear to the total
underwriting discounts and commissions received by the Underwriter. The relative fault shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Company on the one hand or the Underwriter on the other and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission.
The Company and the Underwriter agree that it would not be just and equitable if contributions
pursuant to this Section 7(d) were determined by pro rata allocation or by any other method of
allocation which does not take account of the equitable considerations referred to above in this
Section 7(d). The amount paid or payable by an indemnified party as a result of the losses,
claims, damages or liabilities (or actions or proceedings in respect thereof) referred to above in
this Section 7(d) shall be deemed to include any legal or other expenses reasonably incurred by
such
25
indemnified party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this subsection (d), (i) the Underwriter shall not be required to
contribute any amount in excess of the underwriting discounts and commissions applicable to the
Shares purchased by the Underwriter and (ii) no person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the 0000 Xxx) shall be entitled to contribution from any
person who was not guilty of such fraudulent misrepresentation.
(e) In any proceeding relating to the Registration Statement, any preliminary prospectus, any
Issuer Free Writing Prospectus, the Disclosure Package, the Prospectus or any supplement or
amendment thereto, each party against whom contribution may be sought under this Section 7 hereby
consents to the jurisdiction of any court having jurisdiction over any other contributing party,
agrees that process issuing from such court may be served upon it by any other contributing party
and consents to the service of such process and agrees that any other contributing party may join
it as an additional defendant in any such proceeding in which such other contributing party is a
party.
(f) Any losses, claims, damages, liabilities or expenses for which an indemnified party is
entitled to indemnification or contribution under this Section 7 shall be paid by the indemnifying
party to the indemnified party as such losses, claims, damages, liabilities or expenses are
incurred. The indemnity and contribution agreements contained in this Section 7 and the
representations and warranties of the Company set forth in this Agreement shall remain operative
and in full force and effect, regardless of (i) any investigation made by or on behalf of the
Underwriter, its directors or officers or any person controlling the Underwriter, the Company, its
directors or officers or any persons controlling the Company, (ii) acceptance of any Shares and
payment therefor hereunder, and (iii) any termination of this Agreement. A successor to the
Underwriter, its directors or officers or any person controlling the Underwriter, or to the
Company, its directors or officers, or any person controlling the Company, shall be entitled to
the benefits of the indemnity, contribution and reimbursement agreements contained in this Section
7.
8. Notices.
All communications hereunder shall be in writing and, except as otherwise provided herein,
will be mailed, delivered, telecopied or telegraphed and confirmed as follows: if to the
Underwriter, to Deutsche Bank Securities Inc., 00 Xxxx Xxxxxx, 0xx Xxxxx, Xxx Xxxx, Xxx
Xxxx 00000; Attention: Equity Capital Markets Syndicate Desk, with a copy to Deutsche Bank
Securities Inc., 00 Xxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention: General Counsel, with a copy
to Hunton & Xxxxxxxx LLP, Riverfront Plaza, East Tower, 000 Xxxx Xxxx Xxxxxx, Xxxxxxxx, Xxxxxxxx,
00000, Attention: Xxxxxx X. XxXxx, Esq.; if to the Company, to Urstadt Xxxxxx Properties Inc., 000
Xxxxxxxx Xxxxxx, Xxxxxxxxx, XX 00000, Attention: Xxxxxx X. Xxxxx, with a copy to Xxxxx &
XxXxxxxx LLP, 0000 Xxxxxx xx xxx Xxxxxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention: Xxxxx X.
Xxxxxxxxxxxx.
9. Termination.
(a) This Agreement may be terminated by the Underwriter by notice to the Company (a) at any
time prior to the Closing Date or any Option Closing Date (if different from the Closing Date and
then only as to Option Shares) if any of the following has occurred: (i) since
26
the respective dates
as of which information is given in the Registration Statement, the Disclosure Package and the
Prospectus, any material adverse change or any development which could reasonably be expected to
result in a material adverse change in or to the earnings, business, management, properties,
assets, rights, operations, condition (financial or otherwise) or prospects of the Company and the
Subsidiaries taken as a whole, whether or not arising in the ordinary course of business, (ii) any
outbreak or escalation of hostilities or declaration of war or national emergency or other national
or international calamity or crisis (including, without limitation, an act of terrorism) or change
in economic or political conditions if the effect of such outbreak, escalation, declaration,
emergency, calamity, crisis or change on the financial markets of the United States would, in your
judgment, materially impair the investment quality of the Shares, or (iii) suspension of trading in
securities generally on the New York Stock Exchange, NYSE Amex or the Nasdaq National Market or
limitation on prices (other than limitations on hours or numbers of days of trading) for securities
on either such Exchange, (iv) the enactment, publication, decree or other promulgation of any
statute, regulation, rule or order of any court or other governmental authority which in your
opinion materially and adversely affects or may materially and adversely affect the business or
operations of the Company, (v) the declaration of a banking moratorium by United States or New York
State authorities, (vi) any downgrading, or placement on any watch list for possible downgrading,
in the rating of any of the Company’s debt securities by any “nationally recognized statistical
rating organization” (as defined for purposes of Rule 15(c)3-1(c)(2)(vi)(F) under the 1934 Act);
(vii) the suspension of trading of the Company’s common stock by the New York Stock Exchange, the
Commission, or any other governmental authority or, (viii) the taking of any action by any
governmental body or agency in respect of its monetary or fiscal affairs which in your opinion has
a material adverse effect on the securities markets in the United States; or
(b) as provided in Section 5 of this Agreement.
10. Successors.
This Agreement has been and is made solely for the benefit of the Underwriter and the Company
and their respective successors, executors, administrators, heirs and assigns, and the officers,
directors and controlling persons referred to in Section 7 hereof, and no other person will have
any right or obligation hereunder. No purchaser of any of the Shares from the Underwriter shall be
deemed a successor or assign merely because of such purchase.
11. Information Provided by the Underwriter.
The Company and the Underwriter acknowledge and agree that the only information furnished or
to be furnished by the Underwriter to the Company for inclusion in the Registration Statement, any
preliminary prospectus, any Issuer Free Writing Prospectus or the Prospectus consists of the
information set forth in the ninth, tenth, eleventh and twelfth paragraphs under the caption
“Underwriting” in the preliminary prospectus included in the Disclosure Package and the Prospectus.
12. Miscellaneous.
27
The reimbursement, indemnification and contribution agreements contained in this Agreement and
the representations, warranties and covenants in this Agreement shall remain in full force and
effect regardless of (a) any termination of this Agreement, (b) any investigation made by or on
behalf of the Underwriter or controlling person thereof, or by or on behalf of the Company or its
directors or officers, and (c) delivery of and payment for the Shares under this Agreement.
The Company acknowledges and agrees that the Underwriter in providing investment banking
services to the Company in connection with the offering, including in acting pursuant to the terms
of this Agreement, has acted and is acting as an independent contractor and not as a fiduciary and
the Company does not intend such Underwriter to act in any capacity other than as an independent
contractor, including as a fiduciary or in any other position of higher trust.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument.
This Agreement shall be governed by, and construed in accordance with, the law of the State of
New York, including, without limitation, Section 5-1401 of the New York General Obligations Law.
The Underwriter, on the one hand, and the Company (on its own behalf and, to the
extent permitted by law, on behalf of its stockholders), on the other hand, waive any right to
trial by jury in any action, claim, suit or proceeding with respect to the your engagement as
underwriter or your role in connection herewith.
If the foregoing letter is in accordance with your understanding of our agreement, please sign
and return to us the enclosed duplicates hereof, whereupon it will become a binding agreement among
the Company and the Underwriter in accordance with its terms.
[Signature on next page]
28
Very truly yours, URSTADT XXXXXX PROPERTIES INC. |
||||
By: | /s/ Willing X. Xxxxxx | |||
Name: | Willing X. Xxxxxx | |||
Title: | President | |||
The foregoing Underwriting Agreement is hereby confirmed and accepted as of the date first above written. DEUTSCHE BANK SECURITIES INC. |
||||
By: | /s/ Xxxxxx Xxx | |||
Authorized Officer | ||||
Xxxxxx Xxx, MD | ||||
By: | /s/ Xxxxx Xxxxxxx | |||
Authorized Officer | ||||
Xxxxx Xxxxxxx |
29
SCHEDULE I
Number of shares offered: 2,500,000
Overallotment option: 250,000 shares
Net proceeds to the Company, before estimated offering expenses: $45.1 million
Net proceeds to the Company if overallotment option is exercised in full: $49.6 million
Overallotment option: 250,000 shares
Net proceeds to the Company, before estimated offering expenses: $45.1 million
Net proceeds to the Company if overallotment option is exercised in full: $49.6 million
30
SCHEDULE II
None
31
SCHEDULE III
323 Railroad Corp., a Connecticut Corporation
UB Darien, Inc., a Connecticut Corporation
UB Danbury, Inc., a Connecticut Corporation
UB Xxxxxx, Inc., a New York Corporation
UB Dockside, LLC, a Delaware Limited Liability Company
UB Railside, LLC, a Delaware Limited Liability Company
UB Yorktown, LLC, a Delaware Limited Liability Company
UB Stamford, L.P., a Delaware Limited Partnership
UB Rye, LLC, a New York Limited Liability Company
UB Ironbound L.P., a Delaware Limited Partnership
UB Ironbound GP, LLC, a Delaware Limited Liability Company
UB New Milford, LLC, a Delaware Limited Liability Company
UB Katonah, LLC, a New York, LLC
UB Litchfield, LLC, a Delaware Limited Liability Company
UB Midway I, LLC, a Delaware Limited Liability Company
UB Xxxxxx, LLC, a Delaware Limited Liability Company
UB Solar, Inc., a New Jersey Corporation
Carmel Movie Theater, Inc., a New York Corporation
32
EXHIBIT A
Lock-Up Agreement
September ___, 2010 |
Deutsche Bank Securities Inc.
00 Xxxx Xxxxxx, XX XXX00-0000
Xxx Xxxx, XX 00000
00 Xxxx Xxxxxx, XX XXX00-0000
Xxx Xxxx, XX 00000
Re:
Urstadt Xxxxxx Properties Inc. (the “Company”)
Ladies and Gentlemen:
The undersigned is an owner of record or beneficially of certain shares of Class A common
stock, par value $.01 per share, of the Company (“Class A Common Stock”) or securities convertible
into or exchangeable or exercisable for Class A Common Stock. The Company proposes to carry out a
public offering of Class A Common Stock (the “Offering”) for which you will act as the underwriter.
The undersigned recognizes that the Offering will be of benefit to the undersigned and will
benefit the Company by, among other things, raising additional capital for its operations. The
undersigned acknowledges that you are relying on the representations and agreements of the
undersigned contained in this letter in carrying out the Offering and in entering into underwriting
arrangements with the Company with respect to the Offering.
In consideration of the foregoing, the undersigned hereby agrees that the undersigned will
not, without the prior written consent of Deutsche Bank Securities Inc. (the “Underwriter”) (which
consent may be withheld in its sole discretion), directly or indirectly, sell, offer, contract or
grant any option to sell (including, without limitation, any short sale), pledge, transfer,
establish an open “put equivalent position” within the meaning of Rule 16a-1(h) under the
Securities Exchange Act of 1934, as amended, or otherwise dispose of any shares of Class A Common
Stock, options or warrants to acquire shares of Class A Common Stock, or securities exchangeable or
exercisable for or convertible into shares of Class A Common Stock currently or hereafter owned
either of record or beneficially (as defined in Rule 13d-3 under the Securities Exchange Act of
1934, as amended) by the undersigned (other than as a bona fide gift, provided that the donee
thereof agrees in writing to be bound by this Agreement), or publicly announce the undersigned’s
intention to do any of the foregoing, for a period commencing on the date hereof and continuing to
and including the date that is 90 days after the date of the prospectus supplement of the Company
related to the Offering (the “Initial Lock-Up Period”); provided, however, that if (1) during the
last 17 days of the Initial Lock-Up Period, (A) the Company releases earnings results or (B)
material news or a material event
A-1
relating to the Company occurs, or (2) prior to the expiration of the Initial Lock-Up Period, the
Company announces that it will release earnings results during the 16-day period following the last
day of the Initial Lock-Up Period, then in each case the Lock-Up Period will be extended until the
expiration of the 18-day period beginning on the date of the release of the earnings results or the
occurrence of material news or material event relating to the Company, as the case may be, unless
the Underwriter waives, in writing, such extension. The undersigned also agrees and consents to
the entry of stop transfer instructions with the Company’s transfer agent and registrar against the
transfer of shares of Class A Common Stock or securities convertible into or exchangeable or
exercisable for Class A Common Stock held by the undersigned except in compliance with the
foregoing restrictions.
[Signature on next page]
A-2
Notwithstanding anything herein to the contrary, if the closing of the Public Offering has not
occurred prior to September 30, 2010, this agreement shall be of no further force or effect.
Signature: |
||||
Print Name: |
||||
Number of shares owned | Certificate numbers: | |||
subject to warrants, options | ||||
or convertible securities: | ||||
A-3